Towa Pharmaceutical Co (TWAPF) Q2 2023 Earnings Report
1 Followers
TWAPF Q2 2023 EPS Results
- Actual EPS
- $0.28
- Consensus EPS
- $0.15
- Beat/Miss
- Beat by +$0.13
- One Year Ago EPS
- $0.17
TWAPF Q2 2023 Revenue Results
- Actual Revenue
- $334.57M
- Expected Revenue
- $332.90M
- Beat/Miss
- Beat by +$1.67M
- YoY Revenue Growth
- +17.11%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 11/13/2023
- Time
- TBA
- Conference Call
- Monday, November 13, 2023
TWAPF Upcoming Earnings
Towa Pharmaceutical Co's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
TWAPF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q2) | 0.64- | 0.73 | ― | ― |
| Aug 06, 2026 | 2026 (Q1) | ―0.71 | 0.32 | 120.05% (+0.39) | |
| May 14, 2026 | 2025 (Q4) | 0.68-1.52 | 0.56 | -371.24% (-2.08) | |
| Feb 13, 2026 | 2025 (Q3) | ―1.14 | 1.04 | 9.89% (+0.10) | |
| Nov 10, 2025 | 2025 (Q2) | 0.390.73 | 0.14 | 437.85% (+0.60) | |
| Aug 07, 2025 | 2025 (Q1) | 0.400.32 | 0.71 | -54.26% (-0.38) | |
| May 15, 2025 | 2024 (Q4) | 0.720.56 | -0.09 | 702.22% (+0.65) | |
| Feb 13, 2025 | 2024 (Q3) | 0.371.04 | 0.59 | 76.71% (+0.45) | |
| Nov 12, 2024 | 2024 (Q2) | 0.310.14 | 0.28 | -51.89% (-0.15) | |
| Aug 08, 2024 | 2024 (Q1) | 0.330.71 | 0.61 | 15.68% (+0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
